These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23884065)

  • 1. Hepatitis C virus vaccines among people who inject drugs.
    Cox AL; Thomas DL
    Clin Infect Dis; 2013 Aug; 57 Suppl 2(Suppl 2):S46-50. PubMed ID: 23884065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Echevarria D; Gutfraind A; Boodram B; Layden J; Ozik J; Page K; Cotler SJ; Major M; Dahari H
    Vaccine; 2019 May; 37(19):2608-2616. PubMed ID: 30962092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.
    Hickman M; De Angelis D; Vickerman P; Hutchinson S; Martin NK
    Curr Opin Infect Dis; 2015 Dec; 28(6):576-82. PubMed ID: 26524330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.
    Hope VD; Harris RJ; Vickerman P; Platt L; Shute J; Cullen KJ; Ijaz S; Mandal S; Ncube F; Desai M; Parry JV
    Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliminating hepatitis C: The importance of frequent testing of people who inject drugs in high-prevalence settings.
    Scott N; Sacks-Davis R; Pedrana A; Doyle J; Thompson A; Hellard M
    J Viral Hepat; 2018 Dec; 25(12):1472-1480. PubMed ID: 30047625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
    Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
    Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.
    Hagan H; Pouget ER; Des Jarlais DC
    J Infect Dis; 2011 Jul; 204(1):74-83. PubMed ID: 21628661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.
    Zelenev A; Li J; Mazhnaya A; Basu S; Altice FL
    Lancet Infect Dis; 2018 Feb; 18(2):215-224. PubMed ID: 29153265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland.
    Fraser H; Mukandavire C; Martin NK; Goldberg D; Palmateer N; Munro A; Taylor A; Hickman M; Hutchinson S; Vickerman P
    Addiction; 2018 Nov; 113(11):2118-2131. PubMed ID: 29781207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings: focus group discussions with healthcare providers in Kenya.
    Seu R; Riback LR; Nyakowa M; Lizcano J; Musyoki H; Ross J; Cherutich P; Kurth AE; Akiyama MJ
    Glob Public Health; 2022 Dec; 17(12):3627-3637. PubMed ID: 35941717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention.
    Martin NK; Vickerman P; Dore GJ; Hickman M
    Curr Opin HIV AIDS; 2015 Sep; 10(5):374-80. PubMed ID: 26248124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.
    Coupland H; White B; Bates A; Park JN; Iversen J; Maher L
    Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
    Stone J; Martin NK; Hickman M; Hellard M; Scott N; McBryde E; Drummer H; Vickerman P
    PLoS One; 2016; 11(5):e0156213. PubMed ID: 27224423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
    Fadnes LT; Aas CF; Vold JH; Ohldieck C; Leiva RA; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA;
    BMC Infect Dis; 2019 Nov; 19(1):943. PubMed ID: 31703669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.
    White B; Madden A; Prins M; Hellard M; Wand H; Dore GJ; Page K; Maher L
    Vaccine; 2014 Sep; 32(42):5460-7. PubMed ID: 25131726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012-2022: A Multicenter, Retrospective Study.
    Kim J; Choi GH; Jang OJ; Chon Y; Cho SN; Kwon D; Jeong SH
    J Korean Med Sci; 2023 Dec; 38(48):e357. PubMed ID: 38084024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs.
    Walsh N; Verster A; Rodolph M; Akl EA
    Int J Drug Policy; 2014 May; 25(3):363-71. PubMed ID: 24561223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.
    Grebely J; Prins M; Hellard M; Cox AL; Osburn WO; Lauer G; Page K; Lloyd AR; Dore GJ;
    Lancet Infect Dis; 2012 May; 12(5):408-14. PubMed ID: 22541630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs.
    Park JN; White B; Bates A; Enriquez J; Liao L; Maher L
    Drug Alcohol Depend; 2012 Jun; 123(1-3):35-40. PubMed ID: 22071117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.